Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Chest Radiotherapy and Oral Navelbine for Advanced NSCLC
NCT00256815Phase 2Completed
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in non-small cell lung cancer (NSCLC). Primary endpoints: Safety and Toxicity. Started Mar 2003; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00256815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00256815.